期刊文献+

泸州地区8家医院儿科处方干预前后对比分析

Pediatric Prescriptions in 8 Hospitals of Luzhou Area before and after Intervention: A Contract Analysis
下载PDF
导出
摘要 目的:了解泸州地区基层医院儿科处方情况,促进儿科处方书写的规范性与用药的合理性。方法:以随机抽样法抽取泸州地区8家医院干预前(2011年9—12月)和干预后(2012年9—12月)儿科处方各1 600张,进行处方核心指标统计及处方合理性评价。结果:该地区干预前后平均每张处方用药品种数分别为2.67、2.38种,抗菌药物使用率分别为41.25%、26.81%,注射剂使用率分别为13.56%、9.94%,基本药物使用率分别为38.62%、43.20%,药品通用名使用率分别为87.15%、95.90%,处方平均金额分别为84.08、88.87元;干预前后儿科不合理处方比例分别为24.81%、9.57%。结论:该地区儿科处方基本合理,但仍存在不合理情况,临床医师及药师应共同努力,以达到提高处方质量、保障患者用药安全的目的。 OBJECTIVE:To investigate the pediatric prescriptions in primary hospitals of Luzhou area so as to promote the standardization in prescription writing and rationality of drug use. METHODS: 1600 pediatric prescriptions sampled randomly during Sep. -Dec. period of 2011 (pre-intervention) and another 1600 sampled randomly during Sep. -Dec. period of 2012 ( after intervention) from 8 hospitals of Luzhou area were given statistical analysis regarding the core indicators and evaluation of rationality of prescriptions. RESULTS: In Luzhou area, an average of 2, 67 (before intervention) vs. 2.38 (after intervention) drugs were prescribed per prescription, with antibiotic use rate of 41.25% vs. 26. 81%, injection use rate of 13.56% vs. 9.94 %, rate of essential drug use of 38.62% vs. 43.20%, rate of drugs prescribed in their common names of 87.15% vs. 95.90% , average drug cost per prescription of 84.08 vs. 88.87 yuan, ratio of irrational prescriptions of 24. 81% vs. 9.57%. CONCLUSION: The drug use for the pediatric outpatients in this area is rational on the whole yet it is far from perfect. Clinicians and pharmacists should work together to improve the quality of the prescriptions and ensure patients' medication safety.
出处 《中国医院用药评价与分析》 2013年第6期559-561,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
基金 四川医事卫生法治研究中心青年基金资助项目(编号:YF10-Q06)
关键词 泸州地区 儿科 处方 分析 Luzhou area Pediatric Prescriptions Analysis
  • 相关文献

参考文献5

  • 1卫生部.处方管理办法[S].卫医发[2007]53号
  • 2中华人民共和国卫生部.医院处方点评管理规范(试行)[S].卫医管发[2010]28号.
  • 3卫生部.抗菌药物临床应用管理办法[s].卫生部令[2012]84号.
  • 4卫生部.2012年全国抗茵药物临床应用专项整治活动方案[S].卫办医政发[2012]32号.
  • 5国家药典委员会.中华人民共和国药典·临床用药须知[S].北京:人民卫生出版社,2005:657-658.

共引文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部